$KBH

After-Hours Movers: KBH, WOR, IONQ, TLSI, INNV

KB Home (KBH) rose 2% post-market on strong sector signals. Worthington Enterprises (WOR) surged 14% after Q1 earnings beat estimates. IonQ (IONQ) climbed 8% on quantum error correction milestone. TriSalus Life Sciences (TLSI) jumped 28% after FDA clearance. InnovAge (INNV) dropped 12% on secondary stock offering.

Original reporting
Published Sep 22, 2026, 8:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 9:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$KBH
Bullish
medium confidence
Mentioned
$KBH · $WOR · $IONQ · $TLSI · $INNV
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$KBHBullishMed
01

Why it matters

Each ticker experienced a material price move tied to fresh corporate news, offering short‑term trading opportunities.

02

Market read

The article provides fresh, actionable news for each company, with mixed sentiment across sectors.

03

What to watch

Potential supply‑chain constraints for Worthington and regulatory timelines for IonQ's technology could affect longer‑term outcomes.

Relevance 5/10Novelty 6/10Timing: after‑hours today

Background

After‑hours market recap highlighting five U.S. listed companies with distinct catalysts.

Company-level read

Ticker impact

$KBHBullishMedium confidence
Context

KB Home rose 2% in post‑market trading after sector read‑throughs and stronger buyer demand.

Expected impact

Potential short‑term upside if demand holds.

Evidence & confidence

2% after‑hours gain suggests momentum; no new earnings data, but demand cues may attract traders.

$WORBullishHigh confidence
Context

Worthington Enterprises surged 14% after reporting Q1 EPS of $0.82 beating estimates and 13.2% YoY sales growth.

Expected impact

Likely continued buying pressure in early session.

Evidence & confidence

Quarterly beat and revenue growth are fresh material; 14% move indicates significant market reaction.

$IONQBullishMedium confidence
Context

IonQ climbed 8% after announcing a real‑time quantum error‑correction decoder that runs on a standard CPU.

Expected impact

Short‑term rally may persist as investors price the breakthrough.

Evidence & confidence

First‑time claim of end‑to‑end error correction is novel and could boost valuation.

$TLSIBullishHigh confidence
Context

TriSalus Life Sciences jumped 28% after receiving FDA 510(k) clearance for its TriNav® Advance device.

Expected impact

Expect further upside as sales ramp up.

Evidence & confidence

FDA clearance is a material catalyst; 28% move reflects strong market response.

$INNVBearishMedium confidence
Context

InnovAge fell 12% following the launch of a 10 million‑share secondary offering with an over‑hang.

Expected impact

Downward pressure likely to continue until offering completes.

Evidence & confidence

Large secondary raise creates supply shock; 12% drop signals negative sentiment.

Market effects

Housing demand, building products, quantum tech, med‑tech, and healthcare financing each see fresh catalysts.

U.S. equities see varied moves; sector breadth may influence broader indices.

Limited to U.S. listed companies; no direct global macro effect.

Counterpoint

The sharp moves may be over‑reactions; fundamentals could temper gains for KBH, WOR, IONQ, TLSI, while INNV's dilution risk may be overstated.

Key entities

  • KB Home

    Homebuilder

  • Worthington Enterprises

    Building products manufacturer

  • IonQ

    Quantum computing firm

  • TriSalus Life Sciences

    Medical device maker

  • InnovAge Holding Corp.

    Healthcare platform

Related articles

$QNTMed

Quantinuum vs. IonQ: Why One Major Wall Street Firm Says This Stock Is the Better Bet

Morgan Stanley upgraded Quantinuum (QNT) to overweight with a $68 price target, citing its leadership in quantum error correction and execution. IonQ (IONQ) kept at equal-weight with a $43 target. Quantinuum leads in error correction, while IonQ has advantages in manufacturability and scalability. Both companies are key players in the quantum computing sector, with Morgan Stanley forecasting a $100B market by 2040.

$IONQHigh

IonQ’s Bold Cash Raise Rattles Investors and Stock

IonQ's stock fell 13.76% after announcing a $2 billion equity and warrant financing deal. The offering, priced at $40 per unit, includes anti-dilution protections and warrants exercisable at $69.46. Analysts cut price targets, with Rosenblatt reducing its target to $70 and Morgan Stanley to $43, citing dilution concerns. Despite the drop, options data show call buying outpacing puts, and the company is advancing its quantum computing roadmap.

$IONQHigh

IonQ prices $40 per unit offering with 20.5M shares, 29.5M pre-funded warrants and 100M Series C warrants

IonQ agreed to sell 20.5M shares, 29.5M pre-funded warrants, and 100M Series C warrants at $40 per unit. Each share or pre-funded warrant is paired with two Series C warrants, exercisable immediately for seven years. Series C warrants have an exercise price of $69.46, while pre-funded warrants have an exercise price of $0.0001. The offering is underwritten by J.P. Morgan, according to the company's SEC filing.

$IONQHighAI 9/10

IonQ, Inc. entered into an underwriting agreement with J.P. Morgan Securities LLC as the sole underwriter, providing for the offer and sale of (i) 20,500,000…

IonQ, Inc. (IONQ) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On October 14, 2026, IonQ, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC as the sole underwriter, providing for the offer and sale of (i) 20,500,000 shares (the “Shares”) of the C

$BMBLHighAI 9/10

Deal Dispatch: Ithaca Holdings Buys Bumble for $1.3B, The Knot Acquires Zola, Character.ai Bankruptcy

Bumble (BMBL) agreed to a $1.3B all-cash acquisition by Ithaca Holdings, becoming privately held. IonQ will acquire Elisity in an all-stock deal up to $1.3B. Agilent (A) to buy Proscia for $240M. Workday (WDAY) acquiring C1.ai. Aurora Cannabis exploring alternatives to Curaleaf's bid. Character.ai filed for bankruptcy, Disney to pay $20M for IP. Getty Images plans Chapter 11, going private with Koch backing.